Viewing Study NCT06118151


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2026-06-14 @ 7:16 PM
Study NCT ID: NCT06118151
Status: COMPLETED
Last Update Posted: 2023-11-07
First Post: 2023-10-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Immunogenicity of a Monovalent mRNA Vaccine Encoding Influenza Hemagglutinin in Adult Participants 18 Years of Age and Older
Sponsor: Sanofi Pasteur, a Sanofi Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Influenza View
None Influenza Immunization View
Keywords: